NCT00534118 · OUTCOME

Acute Graft-versus-host Disease

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant · Source last updated 2020-08-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: 100 days post DLI

What was measured

development of grade III-IV acute graft-versus-host disease (GVHD) per Glucksberg criteria

Analysis population: Each accrual is evaluable for acute GVHD grade III-IV

Groups in this outcome

Multiple DLI

Accruals where the patient received 2-4 donor lymphocyte infusions Arm includes total number of infusions

Single DLI

accruals where the patient received only one donor lymphocyte infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Multiple DLI	17
Single DLI	22

Reported measurements

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Multiple DLI	0	Not reported	Not reported	Not reported	Not reported
Single DLI	4	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
0
group Id
OG001
value
4

denoms

counts
group Id
OG000
value
17
group Id
OG001
value
22
units
Participants

description

development of grade III-IV acute graft-versus-host disease (GVHD) per Glucksberg criteria

groups

description
Accruals where the patient received 2-4 donor lymphocyte infusions Arm includes total number of infusions
id
OG000
title
Multiple DLI
description
accruals where the patient received only one donor lymphocyte infusion
id
OG001
title
Single DLI

param Type

COUNT_OF_PARTICIPANTS

population Description

Each accrual is evaluable for acute GVHD grade III-IV

reporting Status

POSTED

time Frame

100 days post DLI

title

Acute Graft-versus-host Disease

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice